GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr
GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at Rs 296 crore for the third quarter ended December 31, 2025.
 "GlaxoSmithKline, gsk")
GlaxoSmithKline (File Photo)
Listen to This Article
GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at ₹296 crore for the third quarter ended December 31, 2025.
The drugmaker reported a profit after tax of ₹230 crore for the October-December period of last fiscal.
Revenue from operations rose to ₹1,041 crore from ₹949 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals Ltd said in a regulatory filing.
The company said its competitive performance comes against the backdrop of the broader macro environment and efforts to mitigate internal supply challenges.
The implementation of the new Labour Codes did not have a material impact on the company, it added.
Shares of the company on Monday settled 1.01 per cent up at ₹2,511 apiece on BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
More From This Section
 "markets, stock markets, indian stock markets")
 "The Union Ministry of Finance will dilute a 6.78 per cent stake in public-sector reinsurance company General Insurance Corporation of India (GIC) Re to garner around Rs 4,700 crore. GIC Re")
 "State Bank of India, SBI")
 "banking, state banks")
 "BSE, Stock Markets")
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 09 2026 | 4:30 PM IST